Dietary fat and colon cancer

Advances in Experimental Medicine and Biology

Volumn 399, Issue , 1996, Pages 157-163

  Hecht, J R ^a  

^a Digestive Disease Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAT; NONSTEROID ANTIINFLAMMATORY AGENT; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE;

CANCER EPIDEMIOLOGY; COLON CARCINOGENESIS; COLON CARCINOMA; CONFERENCE PAPER; FAT INTAKE; FOOD COMPOSITION; HUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0029854461     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4613-1151-5_12     Document Type: Conference Paper

References (85)

1. Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA Cancer J Clin. 1995;45:8-30.
2. Wynder EL, Shigematsu T. Environmental factors of cancer of the colon and rectum. Cancer. 20:1520-61, 1967.
3. Phillips RS. Role of life style and dietary habits in risk of cancer among Seventh-Day Adventists. Cancer Res. 35:3513-22, 1975.
4. Jain M, Cook GM, Davis FG, et al. A case-control study of diet and colo-rectal cancer. Int J Cancer. 26:757-68, 1980.
5. Kune S, Kune GA, Watson LF Case-control study of dietary etiological factors: the Melbourne colorectal cancer study. Nutr Cancer. 9:21-42, 1987.
6. Slattery ML, Schumacher MC, Smith KR, West DW, Abd-elghany. Physical activity, diet, and risk of colon cancer in Utah. Am J Epidemiol. 128: 989-99, 1988.
7. Graham S, Marshall J, Haughey B, et al. Dietary epidemiology of cancer in western New York. Am J Epidemiol. 128: 490-503, 1988.
8. Stemmerman GN, Heilbrun LK, Nomura AMY. Association of diet and other factors with adenomatous polyps of the large bowel: a prospective study. Am J Clin Nutr. 47:312-7, 1988.
9. Mc Keigue PM, Adelstein AM, Marmot MG, et al. Diet and fecal steroid profile in a South Asian population with a low cancer rate. Am J Clin Nutr. 50:151-4, 1989.
10. Goettler D, Rao AV, Bird RP. The effects of a low-risk diet on cell proliferation and enzymatic parameters of preneoplastic rat colon. Nutr Cancer. 1987;10:149-62.
11. Nigro ND, Singh DV, Campbell RL, and Pak, RL. Effect of dietary beef fat on intestinal tumor formation by azoxymethane in rats. J Natl Cancer Inst. 1975; 54:429-42.
12. Reddy BS. Dietary fat and colon cancer: animal models. Prevent Med. 1987;16:460-7.
13. Zhao LP. Kushi LH, Klein RD, Prentice RL. Quantitative review of studies of dietary fat and rat colon carcinoma. Nutr Cancer. 1991;15:169-77.
14. Lindner MA. A fish oil diet inhibits colon cancer in mice. Nutr. Cancer. 1991;15:1-11.
15. Dupont J, White P, Carpenter MP, et al. Food uses and effects of com oil. J Am Coll Nutr. 1990; 9:438-70,.
16. Reddy BS and Maeura Y. Tumor promotion by dietary fat in azoxymethane-induced colon carcinogenesis in female F344 rats: influence of amount and source of dietary fat. JNCI. 72:745-50, 1974.
17. Willett WC, Stampfer MJ, Colditz, GA, Rosner B, Speizer FE. Relationship of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med. 323:1664-72, 1990.
18. Blot WJ, Lanier A, Fraumeni JF Jr. Cancer mortality among Alaskan natives. 1960-1969. J Natl Cancer Inst. 1975; 55:546-54. (CHECK)
19. Reddy BS, Burill C, Rigotty J. Effect of diets high in omega-3 and omega-6 fatty acids on initiation and postinitiation stages of colon carcinogenesis. Cancer Res. 51:487-91, 1991.
20. Narisawa T, Takahashi M, Kotanagi H, et al . Inhibitory effect of dietary perilla oil rich in the n-3 polyunsaturated fatty acid alpha-linoleic acid on colon carcinogenesis in rats. Jpn J Cancer Res. 82:1089-96, 1991.
21. Stenson WF, Cort D, Rodgers J. Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med. 1992;116:609-14.
22. Anti M, Marra G, Armelao F. Effect of w-3 fatty acids on rectal mucosal cell proliferation in subjects at risk for colon cancer. Gastroenterol. 1992;103:883-91.
23. Cannizzo F, Broitman SA. Postpromotional effects of dietary marine or safflower oils on large bowel or pulmonary implants of CT-26 in mice. Cancer Res. 1989;49:4289-94.
24. Hoffmann AF. The enterohepatic circulation of bile acids in health and disease. In: Sleisenger MH and Fordtran JS, eds. Gastrointestinal disease: pathophysiology, diagnosis, management. Philadelphia: W. B. Saunders, 1989:144-161.
25. Mannes GE, Maier A, Thieme C, Wiebecke B, and Paumgartner G. Relation between the frequency of colorectal adenoma and the serum cholesterol level. N Engl J Med. 1986:315:1634-8.
26. Tornberg SA, Holm L-E, Carstensen JM, Eklund GA. Risks of cancer of the colon and rectum in relation to serum cholesterol and beta-lipoprotein. N Engl J Med. 1986;315:1629-33.
27. Hill MJ, Draser BS, Aries V, et al. Bacteria and aetiology of cancer of the large bowel. Lancet. 1977; 1:95-100.
28. Reddy BS. Dietary fat and its relationship to large bowel cancer. Cancer Res. 1981; 41:3700-5.
29. Hill MJ, Draser BE, Williams REO, et al. Faecal bile-acids and clostridia in patients with cancer of the large bowel. Lancet. 1975;1:535-8.
30. Linos DA, Beard CM, O'Fallon W. Cholecystectomy and carcinoma of the colon. Curr Surg. 1981; 38:391-3.
31. Reddy BS, Mastromarino A, Wynder EL. Further leads on metabolic epidemiology of large bowel cancer. Cance Res. 1975;35:3403-6.
32. Reddy BS and Wynder EL. Metabolic epidemiology of colon cancer: fecal bile acids and neutral sterols in colon cancer patients with adenomatous polyps. Cancer. 1977; 39:2533-9.
33. Chomchai C, Bhadrachari N, Nigro ND. The effect of bile on the induction of experimental intestinal tumors in rats. Dis Colon Rectum. 1974;17:310-2.
34. Reddy BS, Narasawa T, Weisburger JH, Wynder EL. Promoting effect of deoxycholic acid on colonic adenocarcinomas in germfree rats. J Natl Cancer Inst. 1976;56:441-2.
35. Reddy BS and Watanabe K. Effect of cholesterol metabolites and promoting effect of lithocholic acid on colon carcinogencsis in germfree and conventional F344 rats. Cancer Res. 1979;39:1521-4.
36. Narisawa T, Magadia NE, Weisberger JH, Wynder EL. Promoting effect of bile acid on colon carcinogenesis after intrarectal installation of N-methyl-N′-nitro-nitrosoguanidine in rats. J Natl Cancer Inst. 1974;53:1093-7.
37. Cohen BI, Raicht RF, Deschner EE, et al. Effect of cholic acid feeding on N-methyl-N-nitrosourea-induced colon tumors and cell kinetics in rats. J Natl Cancer Inst. 1980;64:573-6.
38. Bagheri SA, Bolt MG, Boyer JL, Palmer RH. Stimulation of thymidine incorporation in mouse liver and biliary tract epithelium by lithocholate and deoxycholate. Gastroenterol. 1978;7:188-92.
39. Ranken, R, Wilson R, Bealmer PM. Increased turnover of intestinal mucosal cells of germfree mice induced by cholic acid. Proc Soc Exp Biol Med. 1971;138:270-2.
40. Reddy BS and Wynder EL. Metabolic epidemiology of colon cancer: fecal bile acids and neutral sterols in colon cancer patients with adenomatous polyps. Cancer. 1977; 39:2533-9.
41. Reddy BS. Dietary fat and its relationship to large bowel cancer. Cancer Res. 1981; 41:3700-5.
42. Goldin BR, Swenson L, Dwyer J, Sexton M, Gorbach SL. Effect of diet and lactobacillus acidophilus supplements on human feel bacterial enzymes. J Natl Cancer Inst. 1980;64:255-61.
43. Turjman N, Goodman GT, Jaeger B, Nair PP. Diet, nutrition intake, and metabolism in populations at high and low risk for colon cancer: Metabolism of bile acids. Am J Clin Nutr. 1984;40(suppl):937-41.
44. Goldin BR, Swenson L, Dwyer J, Sexton M, Gorbach SL. Effect of diet and lactobacillus acidophilus supplements on human feel bacterial enzymes. J Natl Cancer Inst. 1980;64:255-61.
45. Reddy BS, Hanson D, Mangat B, et al. Effect of high-fat, high-beef diet and of mode of cooking of beef in the diet on fecal bacterial enzymes and fecal bile acids and neutral sterols. J Nutr. 1980;110:1880-7.
46. Moore PK. Prostanoids. New York: Cambridge University Press, 1985, 68-235.
47. Wahle, KW. Dietary regulation of essential fatty acid metabolism and membrane phospholipid composition. Biochem Soc Trans. 18:775-8, 1990.
48. Murphy RC. Biosynthesis and metabolism. In: Watkins WD, et al. Prostaglandins in Clinical Practice. New York: Raven Press, 1989:1-19.
49. van den Bosch H. Intracellular phospholipases A. Biochim Biophys Acta. 1980; 604: 191-246.
50. Awad AB, Ferger SL, Fink CS. Effect of dietary fat on the lipid composition and utilization of short-chain fatty acids by rat colonocytes. Lipids. 25:316-20, 1990.
51. Hillier K, Jewell R, Dorrell L, Smith CL. Incorporation of fatty acids from fish oil and olive oil into colonic mucosal lipids and effects upon eicosanoid synthesis in inflammatory bowel disease. Gut 32:1151-5, 1991.
52. Hecht JR and Heber D. Unpublished data.
53. Galli C, Marangoni F, Galella G. Modulation of lipid derived mediators by polyunsaturated fatty acids. Prostaglandins Leukotr Ess Fatty Acids. 1993;48:51-55.
54. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for the aspirin-like drugs. Nature. 231:232-5, 1971.
55. Herschman HR, Fletcher BS, Kujubu DA. TIS10, a mitogen-inducible glucocorticoid-inhibited gene that encodes a second prostaglandin synthase/cyclooxygenase enzyme. J Lipid Mediat. 1993; 6:89-99.
56. Bennett A, Del Tacca M, Stamford IF, Zebro T. Prostaglandins from tumors of human large bowel. Br J Cancer. 1977; 35:881-4.
57. Jaffe BM, Parker AW, Philpott GW. Immunochemical measurement of prostaglandin or prostaglandin-like activity from normal and neoplastic cultured tissue. Surg Forum. 1971; 22:90-2.
58. Yamaguchi A, Ishida T, Nishimura G, Katoh M, Miyazaki I. Investigations of colonic prostaglandins in carcinogenesis in the rat colon. Dis Col Rectum. 1991; 34:572-6.
59. Earnest DL, Hixson LJ, Sim WW, Ahnen D, Alberts DS. Piroxicam as an agent to inhibit colonic neoplasia. Gastroenterology. 1989; 96:A134.
60. Neoptolemos JP, Husband D, Imray C, Rowley S, Lawson N. Arachidonic acid and docosahexanoic acid are increased in human colorectal cancer. Gut. 1991; 32:278-81.
61. Tsuji M and Dubois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell. 1995; 83:493-501.
62. Sano H, Kawahito Y, Wilder RL. Expression of cyclooxygenase-1 and -2 in human colorectal tumors. Cancer Res. 1995;55:3785-9.
63. Sato M, Narisawa T, Sano M, Takahashi T, Goto A. Growth inhibition of transplantable murine colon adenocarcinoma 38 by indomethacin. J Cancer Res Clin. Oncol 1983; 106: 21-6.
64. Olsson NO, Caignard A, Martin MS, Martin F. effect of indomethacin on the growth of colon cancer cells in syngeneic rats. Int J Immunopharmac. 1984; 6:329-334.
65. Hial V, De Mello MCF, Horakova, Beaven M. Antiproliferative activity of anti-inflammatory drugs in two mammalian cell culture lines. J Pharmacol Exp Ther. 1977; 202: 446-54.
66. Hubbard NE, Chapkin RS, Erickson KL. Inhibition of growth and linoleate-enhanced metastasis of a transplantable mouse mammary tumor by indomethacin. Cancer Lett. 1988; 43: 111-20.
67. 1 Phase of the cell cycle by indomethacin. J Pharmol Exp Ther. 1979; 210: 106-11.
68. Pollard M, Luckert PH. Indomethacin treatment of rats with dimethylhydrazine-induced intestinal tumors. Cancer Treat Rep. 1980; 64:1323-7.
69. Narisawa T, Sato M, Tani M, et al. Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment. Cancer Res. 1981; 41:1954-7.
70. Pollard M, Luckert PH, Schmidt MA. The suppressive effect of piroxicam on autochthonous intestinal rumors in the rat. Cancer Lett. 1983; 21:57-67.
71. Reddy BS, Maruyama H, Kelloff G. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development. Cancer Res. 1987; 47:5340-6.
72. Moorghen M, Ince P, Finney KJ, et al. A protective effect of sulindac against chemically-induced primary colonic tumors in mice. J Pathol. 1988; 156: 341-7.
73. Skinner SA. Penney AG, O'Brien PE. Sulindac inhibits the rate of growth and appearance of colon tumors in the rat. Arch Surg. 1991; 126:1094-6.
74. Heneghan JB. Inhibition of human colon tumor growth in nude mice by indomethacin. In: Germfree Research: Microflora control and its application to the biomedical science. Alan Liss, 1985:315-8.
75. Rosenberg L, Palmer JR, Zauber AG. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the risk of large-bowel cancer. J Natl Cancer Inst. 1991; 83: 355-8.
76. Thun MJ, Namboordi MM, Heath CW. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med. 1991; 325:1593-6.
77. Suh O, Mettlin C, Petrelli NJ. Aspirin Use, Cancer, and Polyps of the Large Bowel. Cancer. 1993; 72:1171-7.
78. Giovannucci E, Rimm EB, Stampfer MJ, et al. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med. 1994; 121:241-6.
79. Kinzler KW, Nilbert MC, Su L-K, et al. Identification of FAP locus genes from chromosome 5q21. Science. 1991; 253:661-4.
80. Groden J, Thliveris A, Samowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell. 1991; 66:589-600.
81. Waddell WR, Loughry RW. Sulindac for polyposis of the colon. J Surg Oncol. 1983; 24:83-7.
82. Waddell WR, Ganser GF, Cerise EJ, Loughry RW. Sulindac for polyposis of the colon. Am J Surg. 1989; 157: 175-9.
83. Min-induced intestinal neoplasia. Cell. 1995;81:957-66.
84. Droy-Lefaix MT. Prostanoids and stomach physiology, and In: Curtis-Prior PB, ed. Prostaglandins: biology and chemistry of prostaglandins and related eicosanoids. Edinburgh; Churchill Livingstone. 1988; 345-60.
85. Morham SG, Langenbach R, Loftin CD, etal. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell. 1995;83:473-82.